These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 15010342)

  • 1. Protein mis-folding emerges as a "drugable" target for discovery of novel therapies for neuropsychiatric diseases of aging.
    Trojanowski JQ
    Am J Geriatr Psychiatry; 2004; 12(2):134-5. PubMed ID: 15010342
    [No Abstract]   [Full Text] [Related]  

  • 2. Phage M13 for the treatment of Alzheimer and Parkinson disease.
    Messing J
    Gene; 2016 Jun; 583(2):85-89. PubMed ID: 26869319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tau and Parkinson disease.
    Spillantini MG; Goedert M
    JAMA; 2001 Nov; 286(18):2324-6. PubMed ID: 11710900
    [No Abstract]   [Full Text] [Related]  

  • 4. Alpha-synuclein and Parkinson's disease.
    Golbe LI
    Adv Neurol; 2003; 91():165-74. PubMed ID: 12442675
    [No Abstract]   [Full Text] [Related]  

  • 5. alpha-Synuclein--a link between Parkinson and Alzheimer diseases?
    Heintz N; Zoghbi H
    Nat Genet; 1997 Aug; 16(4):325-7. PubMed ID: 9241262
    [No Abstract]   [Full Text] [Related]  

  • 6. Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies.
    Goedert M
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1101-18. PubMed ID: 10434313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synuclein aggregation: possible role in traumatic brain injury.
    Bramlett HM; Dietrich WD
    Exp Neurol; 2003 Nov; 184(1):27-30. PubMed ID: 14637075
    [No Abstract]   [Full Text] [Related]  

  • 8. Gene discovery offers tentative clues to Parkinson's.
    Vogel G
    Science; 1997 Jun; 276(5321):1973. PubMed ID: 9221499
    [No Abstract]   [Full Text] [Related]  

  • 9. [Tauopathy and Alzheimer disease: a full degenerating process].
    Buée L; Delacourte A
    Psychol Neuropsychiatr Vieil; 2006 Dec; 4(4):261-73. PubMed ID: 17194646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attack on amyloid.
    Kahle PJ; De Strooper B
    EMBO Rep; 2003 Aug; 4(8):747-51. PubMed ID: 12897797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutated tau, amyloid and neuroinflammation in Alzheimer disease-A brief review.
    Hung AS; Liang Y; Chow TC; Tang HC; Wu SL; Wai MS; Yew DT
    Prog Histochem Cytochem; 2016 May; 51(1):1-8. PubMed ID: 26851150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Heterogeneity of Parkinson's disease].
    Vidailhet M
    Bull Acad Natl Med; 2003; 187(2):259-75; discussion 275-6. PubMed ID: 14556440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Progress in diagnosis and therapy for Parkinson's disease].
    Mizuno Y
    Nihon Naika Gakkai Zasshi; 2002 Aug; 91(8):2344-8. PubMed ID: 12373846
    [No Abstract]   [Full Text] [Related]  

  • 14. [Synucleins--the key to mechanisms of neurodegenerative diseases?].
    Buchman VL
    Mol Biol (Mosk); 1998; 32(4):592-7. PubMed ID: 9785560
    [No Abstract]   [Full Text] [Related]  

  • 15. NACP/alpha-synuclein, NAC, and beta-amyloid pathology of familial Alzheimer's disease with the E184D presenilin-1 mutation: a clinicopathological study of two autopsy cases.
    Yokota O; Terada S; Ishizu H; Ujike H; Ishihara T; Nakashima H; Yasuda M; Kitamura Y; Uéda K; Checler F; Kuroda S
    Acta Neuropathol; 2002 Dec; 104(6):637-48. PubMed ID: 12410385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tau gene mutations and their effects.
    Goedert M
    Mov Disord; 2005 Aug; 20 Suppl 12():S45-52. PubMed ID: 16092090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's disease and Parkinson's disease.
    Nussbaum RL; Ellis CE
    N Engl J Med; 2003 Apr; 348(14):1356-64. PubMed ID: 12672864
    [No Abstract]   [Full Text] [Related]  

  • 18. Neurodegenerative disease: amyloid pores from pathogenic mutations.
    Lashuel HA; Hartley D; Petre BM; Walz T; Lansbury PT
    Nature; 2002 Jul; 418(6895):291. PubMed ID: 12124613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene dosage and pathogenesis of Parkinson's disease.
    Eriksen JL; Przedborski S; Petrucelli L
    Trends Mol Med; 2005 Mar; 11(3):91-6. PubMed ID: 15760766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parkinson's disease and dementia with Lewy bodies: a difference in dose?
    Singleton A; Gwinn-Hardy K
    Lancet; 2004 Sep 25-Oct 1; 364(9440):1105-7. PubMed ID: 15451205
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.